The TOX–RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases
Proceedings of the National Academy of Sciences · 25.06.2024 · 121 (26)
DOI: 10.1073/pnas.2319322121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.06.2024. Verfasst von Hyelim Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Brain Science Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea. Hauptthemen laut MEDLINE: High Mobility Group Proteins, Glycation End Products, Advanced, COVID-19, Lung Injury. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Korea Basic Science Institute (KBSI).
Abstract (Originalsprache)
Thymocyte selection–associated high-mobility group box (TOX) is a transcription factor that is crucial for T cell exhaustion during chronic antigenic stimulation, but its role in inflammation is poorly understood. Here, we report that TOX extracellularly mediates drastic inflammation upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by binding to the cell surface receptor for advanced glycation end-products (RAGE). In various diseases, including COVID-19, TOX release was highly detectable in association with disease severity, contributing to lung fibroproliferative acute respiratory distress syndrome (ARDS). Recombinant TOX-induced blood vessel rupture, similar to a clinical signature in patients experiencing a cytokine storm, further exacerbating respiratory function impairment. In contrast, disruption of TOX function by a neutralizing antibody and genetic removal of RAGE diminished TOX-mediated deleterious effects. Altogether, our results suggest an insight into TOX function as an inflammatory mediator and propose the TOX–RAGE axis as a potential target for treating severe patients with pulmonary infection and mitigating lung fibroproliferative ARDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain Science Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea.
- Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
- Department of Bioengineering, Hanyang University, Seoul 04763, Republic of Korea.
- Research Institute for Convergence of Basic Science, Hanyang University, Seoul 04763, Republic of Korea.
- Division of Bio-Medical Science and Technology (Korea Institute of Science and Technology School), Korea University of Science and Technology, Seoul 02792, Republic of Korea.
- School of Mechanical Engineering, Yonsei University, Seoul 03722, Republic of Korea.
ORCID-Profile: Hyelim Kim, Hee Ho Park, Hong Nam Kim, Donghyuk Seo, June Hong Ahn, Wonhwa Lee
Förderung
- National Research Foundation of Korea (NRF)
- Korea Basic Science Institute (KBSI)
Zitieren
APA
Kim, H., Park, H. H., Kim, H. N., Seo, D., Hong, K. S., Jang, J. G., Seo, E. U., Kim, I. Y., Jeon, S. Y., Son, B., Cho, S. W., Kim, W., Ahn, J. H., & Lee, W. (2024). The TOX–RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases. Proceedings of the National Academy of Sciences, 121(26). https://doi.org/10.1073/pnas.2319322121
Vancouver
Kim H, Park HH, Kim HN, Seo D, Hong KS, Jang JG, et al. The TOX–RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases. Proceedings of the National Academy of Sciences. 2024;121(26). doi:10.1073/pnas.2319322121
BibTeX
@article{Kim2024,
author = {Kim, Hyelim and Park, Hee Ho and Kim, Hong Nam and Seo, Donghyuk and Hong, Kyung Soo and Jang, Jong Geol and Seo, Eun U and Kim, In-Young and Jeon, So-Young and Son, Boram and Cho, Seong-Woo and Kim, Wantae and Ahn, June Hong and Lee, Wonhwa},
title = {The TOX–RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {26},
doi = {10.1073/pnas.2319322121}
}
EUVIMED